This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Helen of Troy (HELE) Spins Off Market Personal Care Business
by Zacks Equity Research
Helen of Troy (HELE) divests mass market Personal Care business (excluding the Latin America and Caribbean regions) to HRB Brands LLC as part of its strategy to focus on Leadership Brands.
Zacks Industry Outlook Highlights: Estee Lauder, Coty, Nu Skin and Inter Parfums
by Zacks Equity Research
Zacks Industry Outlook Highlights: Estee Lauder, Coty, Nu Skin and Inter Parfums
4 Cosmetics Stocks Stealing Attention Despite Industry Woes
by Vrishali Bagree
The Zacks Cosmetics industry is battling COVID-19 hurdles like disrupted travel retail and low store traffic. However, high demand for personal care products and focus on innovation bodes well for Estee Lauder (EL), Coty (COTY), Nu Skin (NUS) and Inter Parfums (IPAR).
Coty (COTY) Poised on Strength in Core Priorities & Partnerships
by Zacks Equity Research
Coty (COTY) makes several strategic partnerships to enhance its brand portfolio. Also, it is on track with six priorities aimed at sustainable growth.
The Estee Lauder Companies (EL) Looks Poised on Online Sales
by Zacks Equity Research
The Estee Lauder Companies (EL) is benefiting from growing online sales. Also, the company's Skin Care portfolio looks impressive.
Will Inter Parfums (IPAR) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Inter Parfums (IPAR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Inter Parfums (IPAR) Q1 Earnings Top Estimates, Increase Y/Y
by Zacks Equity Research
Inter Parfums' (IPAR) first-quarter 2021 results reflect strong top and bottom lines. Solid performances in regions where lockdowns have been eased benefit results.
Inter Parfums (IPAR) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Inter Parfums (IPAR) delivered earnings and revenue surprises of 38.10% and 0.02%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Nu Skin (NUS) Stock Gains on Q1 Earnings Beat & Raised View
by Zacks Equity Research
Nu Skin's (NUS) first-quarter 2021 earnings and revenues increase year over year on growth in sales leaders and customer base. Also, management raises 2021 view.
Things You Must Know Before Inter Parfums' (IPAR) Q1 Earnings
by Zacks Equity Research
Inter Parfums' (IPAR) first-quarter 2021 results are likely to reflect sales growth on strength in U.S. and European operations.
Inter Parfums (IPAR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Inter Parfums (IPAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inter Parfums (IPAR) Stock Up on Solid Q1 Sales & Raised View
by Zacks Equity Research
Inter Parfums (IPAR) sees solid sales growth in the first quarter of 2021, with strength in U.S. and European operations. Further, management raises 2021 view.
Inter Parfums' (IPAR) Subsidiary Acquires Office Building Complex
by Zacks Equity Research
Inter Parfums' (IPAR) subsidiary concludes the acquisition of its envisioned headquarters from Apsys for nearly $149 million. The company will host all teams in the location by spring 2022.
Inter Parfums (IPAR) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Inter Parfums (IPAR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Coty (COTY) to Team Up With LanzaTech for its Fragrance Business
by Zacks Equity Research
Coty (COTY) intends to partner with LanzaTech to have most of its fragrance portfolio made using carbon-captured ethanol by 2023.
Inter Parfums (IPAR) Q4 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
Inter Parfums' (IPAR) fourth-quarter 2020 sales and earnings rise year over year. Also, management raises 2021 guidance.
Nu Skin (NUS) More Than Double in a Year: Will Momentum Stay?
by Zacks Equity Research
Nu Skin (NUS) is benefiting from initiatives to strengthen sales leader and expand customer base. Also, the company's focus on digital operations is impressive.
Inter Parfums (IPAR) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Positive impact of cost-containment efforts is likely to get reflected in Inter Parfums' (IPAR) fourth-quarter 2020 performance.
The Estee Lauder (EL) to Raise Stake in DECIEM to Aid Growth
by Zacks Equity Research
The Estee Lauder (EL) will increase its stake in DECIEM from nearly 29% to roughly 76% for almost $1 billion. The deal is likely to be concluded during the quarter ending Jun 30.
4 Factors That Make The Estee Lauder (EL) a Promising Pick
by Zacks Equity Research
The Estee Lauder's (EL) impressive online business is driving growth. Also, the company's Skin Care portfolio is performing well.
Inter Parfums (IPAR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Inter Parfums (IPAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nu Skin (NUS) Tops Q4 Earnings Estimates, Raises Dividend
by Zacks Equity Research
Growth in sales leaders and customer base drove Nu Skin's (NUS) fourth-quarter 2020 results. Notably, earnings and revenues increased year over year.
Estee Lauder (EL) Q2 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
Estee Lauder's (EL) second-quarter fiscal 2021 sales and earnings increase year over year. However, results reflect impact of some retail store closures and lower traffic in reopened stores amid COVID-19.
Clorox (CLX) Q2 Earnings, Sales Top Estimates on Strong Demand
by Zacks Equity Research
Clorox's (CLX) Q2 sales benefit from double-digit sales growth in the majority of the segments, fueled by strong product demand due to the coronavirus outbreak and related shift in trends.
Inter Parfums (IPAR) Ups 2020 Earnings View on Solid Q4 Sales
by Zacks Equity Research
Inter Parfums' (IPAR) sales increase year over year in fourth-quarter 2020. Management raises 2020 earnings guidance.